Trial intelligence / Profile preview

Anesthesia Technique and CTC in Primary Breast Carcinoma

NCT02005770Phase 4Completed

Sponsor
University of Zurich
Start
Mar 2014
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sevoflurane in breast carcinoma, sponsored by University of Zurich. Started Mar 2014; status: completed.

02

Drugs

sevoflurane
03

Conditions

breast carcinoma

Beyond the preview

Go deeper on NCT02005770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02005770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call